Introduction
============

Lung cancer is a multistep process involving alterations in the expression of oncogenes and tumor suppressor genes via numerous factors, including alcohol, smoking, pathogenic infections and genetic factors ([@b1-etm-0-0-6020]--[@b3-etm-0-0-6020]). Lung cancer is the most frequently diagnosed cancer and its incidence has been increasing in recent years ([@b2-etm-0-0-6020],[@b3-etm-0-0-6020]). It remains a leading cause of cancer-associated mortality worldwide for men and women ([@b4-etm-0-0-6020],[@b5-etm-0-0-6020]), but the pathogenesis of this disease remains unknown ([@b6-etm-0-0-6020]).

PDZ-binding-kinase/T-LAK cell-originated protein kinase (PBK/TOPK) is a 322-amino acid serine/threonine kinase ([@b7-etm-0-0-6020]). In normal tissues, is difficult to detect PBK/TOPK protein, other than in the germ cells of the testis and numerous fetal tissues ([@b8-etm-0-0-6020]). The overexpression of PBK/TOPK has been observed in activated T-LAK cells, which interacted with fruit plate-large human homologues via the C-terminal PDZ binding motif of TOPK ([@b9-etm-0-0-6020]). PBK/TOPK is widely expressed in a variety of malignancies, including leukemia, lymphoma and breast cancer, and malignant peripheral nerve sheath tumors ([@b10-etm-0-0-6020]--[@b12-etm-0-0-6020]). PBK/TOPK overexpression contributes to tumor proliferation and growth in Ewing sarcoma, colorectal cancer and breast cancer ([@b13-etm-0-0-6020],[@b14-etm-0-0-6020]). In lung cancer, patients exhibit poor clinical outcome with high expression of PBK/TOPK ([@b15-etm-0-0-6020]). Recently, PBK/TOPK overexpression was reported to be closely associated with tumor malignancy potential and poor outcome of patients with gastric cancer ([@b16-etm-0-0-6020]). In addition, high expression of PBK/TOPK may serve as a favorable prognostic marker for patients with oral cancer ([@b17-etm-0-0-6020]). In molecular studies, PBK/TOPK expression was associated with cell mitotic regulation, inflammation and apoptosis ([@b18-etm-0-0-6020]).

MicroRNAs (miRNAs/miRs) are non-coding RNAs that inhibit gene expression by inhibiting the translation of target mRNAs or by degrading them. miRNAs have been demonstrated to interact directly with the 3′-untranslated region (3′-UTR) of target mRNAs ([@b19-etm-0-0-6020]). miRNAs regulate numerous cell functions, including proliferation, differentiation, metastasis and apoptosis ([@b19-etm-0-0-6020]). Studies have indicated that altered miRNA expression levels are associated with cancer ([@b20-etm-0-0-6020],[@b21-etm-0-0-6020]). miRNAs may serve as oncogenes or tumor suppressors, depending on the organs and tumors in which they are expressed ([@b22-etm-0-0-6020]--[@b24-etm-0-0-6020]). miR-216b has been studied in a variety of cancer types. For instance, miR-216b was reported to be closely associated with the prognosis of cervical cancer patients and may inhibit cervical cancer cell proliferation via regulating forkhead box protein M1 (FOXM1) expression ([@b25-etm-0-0-6020]). miR-216b prevented the migration and invasion of glioma cells by suppressing FOXM1 expression ([@b26-etm-0-0-6020]). Liu *et al* ([@b27-etm-0-0-6020]) reported that miR-216b was involved in cisplatin resistance in ovarian cancer by the regulation of poly adenosine 5′-diphosphate-ribose polymerase 1. Furthermore, miR-216b may inhibit hepatocellular carcinoma cell proliferation, migration and invasion by regulating insulin-like growth factor 2 mRNA-binding protein 2 ([@b28-etm-0-0-6020]). However, the role and mechanism of miR-216b-3p in lung adenocarcinoma requires further investigation.

The present study aimed to explore the effects of miR-216b-3p on lung adenocarcinoma, and the association between miR-216b-3p and PBK/TOPK. Herein, the molecular functions and underlying mechanism of miR-216b-3p were investigated.

Materials and methods
=====================

### Reagents

Human lung adenocarcinoma cell lines (A549, GLC-82 and H358 cells) and the human normal lung epithelial cell line BEAS-2B were acquired from Scien Cell Research Laboratories, Inc. (San Diego, CA, USA) and cultured in the laboratory. Fetal bovine serum (FBS), penicillin/streptomycin, and trypsin-EDTA were obtained from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Dulbecco\'s modified Eagle medium (DMEM) was obtained from Corning, Inc. (Corning, NY, USA).

### Cell culture

A549, GLC-82, H358 and BEAS-2B cells were cultured in DMEM containing 10% FBS, 100 U/ml penicillin and 100 U/ml streptomycin (pH 7.2) in a 5% CO~2~ atmosphere at 37°C.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis

Total RNA was isolated from A549, GLC-82, H358 and BEAS-2B cells using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer\'s protocol. The first strand cDNA synthesis was performed with 1 µg RNA in the reaction mixture of 10 µl with 50 pmol random hexamers and 50 units of M-MLV RTase. Conditions were as following: 16°C for 30 min, 42°C for 30 min, 85°C for 5 min, and hold at 4°C. Subsequently, qPCR was performed to analyze the synthesized cDNA using the QuantiTect SYBR Green PCR kit (Qiagen GmbH, Hilden, Germany). The master mix (20 µl) contained 2 µl 10× reverse transcription buffer, 1 µl deoxynucleotides (100 mM; with thymidine triphosphate), 0.25 µl 2 µM forward primer, 0.25 µl 2 µM reverse primer, 5 µl 1 ng/µl cDNA and 11.5 µl nuclease-free water. The amplification conditions were as follows: 38 cycles of denaturation at 95°C for 10 sec, followed by 60°C for 60 sec to allow annealing and extension. U6 and GAPDH served as the internal controls for miR-216b-3p and PBK expression respectively. qPCR was conducted with the following primers: miR-216b-3p forward, 5′-CAGGCACACACTTACCCGTA-3′ and reverse, 5′-GCAGGGTCCGAGGTATTC-3′; U6 forward, 5′-CTCGCTTCGGCAGCACATATACT-3′ and reverse, 5′-ACGCTTCACGAATTTGCGTGTC-3′; GAPDH forward, 5′-GAAGGTGAAGGTCGGAGTC-3′ and reverse, 5′-GAAGATGGTGATGGGATTTC-3′; and PBK forward, 5′-CCAAACATTGTTGGTTATCGTGC-3′ and reverse, 5′-GGCTGGCTTTATATCGTTCTTCT-3′. Relative gene expression was calculated by using the 2^−ΔΔCq^ method ([@b29-etm-0-0-6020]). The test was performed three times in triplicate.

### Western blot analysis

Harvested A549, GLC-82, H358 and BEAS-2B cells were briefly washed with cold PBS. On ice, they were lysed in radioimmunoprecipitation complete lysis buffer \[50 mM Tris, pH 7.2; 1% sodium deoxycholate; 150 mM NaCl; 0.1% SDS; 10 mM NaF; 1% Triton-X 100; 1 mM Na3VO4; protease inhibitor cocktail (1:800)\]. Lysates were sonicated 3 times at 4°C, each time 10 sec (frequency, 20 kHz) and centrifuged at 13,000 × g for 10 min at 4°C. Serum albumin was used as the standard and protein concentration was determined with bicinchoninic acid as previously described ([@b30-etm-0-0-6020]). Total protein (30 µg/lane) was separated using 12% SDS-PAGE and transferred to polyvinylidene difluoride membranes. Subsequently, membranes were incubated with PBS containing 0.05% Tween-20 and 5% non-fat dry milk at room temperature for 1.5 h to block non-specific binding and were incubated with PBK/TOPK (cat no. 4942), p53 (Cat no. 2527), p21 (cat no. 2947), p-p38 (cat no. 4511) and β-actin (cat no. 4970) primary antibodies (all 1:1,000; Cell Signaling Technology, Danvers, MA, USA), then treated with anti-rabbit Immunoglobulin G horseradish peroxidase-coupled secondary antibody (cat no. 7074; 1:1,000; Cell Signaling Technology) as described ([@b31-etm-0-0-6020]). Immunoreactive bands were observed with enhanced chemiluminescence using the SignalFire^™^ Plus ECL Reagent (cat no. 12630; Cell Signaling Technology) and imaged by ChemiDoc XRS+ System (Bio-Rad Laboratories). The band density was quantified with Gel-Pro Analyzer densitometry software (version 6.3; Media Cybernetics, Inc., Rockville, MD, USA).

### Transient transfection

Cells were transiently transfected with 50 nM miR-216b-3p mimic (Pre-miR^™^ miR-216b-3p; sense, 5′-AAAUCUCUGCAGGCAAAUGUGA-3′ and antisense, 5′-ACAUUUGCCUCCAGAGAUUUUU-3′; Thermo Fisher Scientific, Inc.), 50 nM negative control (negative control miRNA; sense, 5′-UUCUCCGAACGUGUCACGUTT-3′ and antisense, ACGUGACACGUUCGGAGAATT-3′; Thermo Fisher Scientific, Inc.), 2 µg control plasmids, 2 µg PBK/TOPK plasmids (PBK CRISPR/Cas9 KO Plasmid (h); cat no. sc-404069; Santa Cruz Biotechnology, Inc., Dallas, CA, USA) or 50 nM miR-216b-3p mimic + 2 µg PBK/TOPK plasmids using Lipofectamine^®^ 2000 (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer\'s protocol. Cells were seeded at a density of 5×10^4^ cells per well in a 6-well plate. At 48 h post-transfection, the cells were subjected to subsequent analysis.

### Luciferase reporter assay

Bioinformatics software ([targetscan.org/vert_71](targetscan.org/vert_71)) was used to predict the targets of miR-216b-3p; PBK was identified as a potential target of miR-216b-3p. To determine whether miR-216b-3p directly targets the 3′-UTR of PBK, the psiCHECK-2 reporter plasmid (Sangon Biotech Co., Ltd., Shanghai, China) vectors named PBK-3′UTR-WT and PBK-3′UTR-MUT with wild type and mutated 3′UTR of PBK mRNA, respectively, were constructed as previously described ([@b32-etm-0-0-6020]). GLC-82 cells (5×10^4^ cells/well) were seeded in a 24-well plate and then co-transfected with PBK-3′UTR-WT or PBK-3′UTR-MUT and miR-216b-3p or its negative control (miR-NC) vector using Lipofectamine^®^ 2000 transfection reagent according to the manufacturer\'s protocols. A total of 48 h after transfection, the luciferase activity was detected using the Dual-Luciferase Reporter Assay kit (Promega Corporation, Madison, WI, USA) according to the manufacturer\'s protocol and normalized to *Renilla* luciferase activity.

### Flow cytometry for apoptosis analysis

For apoptosis analysis, 1×10^5^ cells/well were seeded in 6-well plates and incubated in DMEM containing 10% FBS at 37°C for 48 h. After 48 h, the harvested floating and adherent cells were washed twice with cold PBS. Cells were stained with Annexin V-fluorescein isothiocyanate and propidium iodide (cat. no. 6592; Cell Signaling Technology) in 500 µl binding buffer at room temperature for 15 min, and then analyzed with a BD FACSCelesta^™^ flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) using WinMDI (Version 2.5; Purdue University Cytometry Laboratories, West Lafayette, IN, USA) within 1 h ([@b28-etm-0-0-6020]).

### Cell proliferation assay

Cell proliferation was examined by a MTT assay. A total of 48 h after transfection, GLC-82 cells (4×10^3^ cells/well) were seeded into 96-well culture plates and incubated in 5% CO~2~ at 37°C. Then, 20 µl MTT (5 mg/ml) was added to each well and the cells were incubated for another 4 h at 37°C. Following removal of MTT, 100 µl dimethyl sulfoxide was added to each well, and the plate was gently agitated for 10 min at room temperature. The absorbance was measured with a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA) at 490 nm. All experiments were repeated ≥3 times ([@b33-etm-0-0-6020]).

### Statistical analysis

Experiments were performed for at least three times. Data are expressed as the mean ± standard deviation. SPSS 17.0 statistical software (SPSS, Inc., Chicago, IL, United States) was performed for all statistical analyses. Statistical analysis was performed using a Student\'s t-test or one-way analysis of variance followed by Tukey\'s test where appropriate. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Low expression of miR-216b-3p in lung adenocarcinoma cell lines

The expression levels of miR-216b-3p in human lung adenocarcinoma cell lines (A549, GLC-82 and H358 cells) and human normal lung epithelial cell line BEAS-2B were analyzed. The results of the present study indicated that the expression levels of miR-216b-3p in all lung adenocarcinoma cell lines (A549, GLC-82 and H358 cells) were significantly lower compared with BEAS-2B cells. The lowest expression level of miR-216b-3p was in GLC-82 cells ([Fig. 1](#f1-etm-0-0-6020){ref-type="fig"}). Therefore, GLC-82 cells were selected for subsequent *in vitro* studies in the present study.

### Overexpression of PBK/TOPK in lung adenocarcinoma cell lines

Western blotting and RT-qPCR were performed to test whether PBK/TOPK was overexpressed in lung adenocarcinoma cell lines. PBK/TOPK was expressed at low levels within BEAS-2B cells. However, the protein and mRNA expression levels of PBK/TOPK were increased in all lung adenocarcinoma cell lines (A549, GLC-82 and H358 cells), compared with BEAS-2B cells, with the largest increase in GLC-82 ([Fig. 2](#f2-etm-0-0-6020){ref-type="fig"}). These results suggested that PBK/TOPK may be a target of activation in lung adenocarcinoma.

### PBK is a direct target gene of miR-216b-3p

The aforementioned results demonstrated that miR-216b-3p and PBK/TOPK expression may be dysregulated in lung adenocarcinoma cell lines. Therefore, miR-216b-3p and PBK/TOPK may have a direct association. TargetScan was employed to predict the target gene of miR-216b-3p ([Fig. 3A](#f3-etm-0-0-6020){ref-type="fig"}). PBK was identified as a direct target gene of miR-216b-3p and a double luciferase reporter assay revealed the same result ([Fig. 3B](#f3-etm-0-0-6020){ref-type="fig"}).

To investigate the function of miR-216b-3p in lung adenocarcinoma, synthesized miR-216b-3p mimics, miR-NC, control plasmids, PBK/TOPK plasmids or miR-216b-3p mimic + PBK/TOPK plasmids were transfected into GLC-82 cells ([Fig. 3C-F](#f3-etm-0-0-6020){ref-type="fig"}). At 48 h post-transfection, the transfection efficiency was determined by RT-qPCR ([Fig. 3C and F](#f3-etm-0-0-6020){ref-type="fig"}). The results indicated that miR-216b-3p mimics significantly enhanced miR-216-3p expression in GLC-82 cells and PBK/TOPK plasmids significantly increased the mRNA level of PBK/TOPK. To further reveal whether miR-216b-3p may regulate PBK/TOPK in GLC-82 cells, at 48 h after GLC-82 cell transfection with miR-216b-3p mimics or miR-NC, the protein and mRNA expression levels of PBK/TOPK were detected by western blotting and RT-qPCR respectively. The results of the present study indicated that miR-216b-3p mimics may inhibit PBK/TOPK expression in GLC-82 cells ([Fig. 3D and E](#f3-etm-0-0-6020){ref-type="fig"}). Collectively, the data suggested that PBK may be a direct target gene of miR-216b-3p and may be negatively regulated by miR-216b-3p.

### miR-216b-3p overexpression inhibits GLC-82 cell proliferation and induces cell apoptosis via regulating PBK/TOPK expression

Cells were transiently transfected with miR-216b-3p mimics, miR-NC or miR-216b-3p mimics + PBK/TOPK plasmids. An MTT assay was conducted to detect the proliferation of GLC-82 cells; flow cytometry was used to analyze apoptosis. The results demonstrated that miR-216b-3p overexpression significantly inhibits GLC-82 cell proliferation ([Fig. 4](#f4-etm-0-0-6020){ref-type="fig"}) and induces cell apoptosis ([Fig. 5](#f5-etm-0-0-6020){ref-type="fig"}) compared with the control. These effects were eliminated by PBK/TOPK overexpression ([Figs. 4](#f4-etm-0-0-6020){ref-type="fig"} and [5](#f5-etm-0-0-6020){ref-type="fig"}).

### miR-216b-3p overexpression affects p53, p21 and phosphorylated (p) -p38 expression

To further investigate the molecular mechanism of miR-216b-3p, the expression of p53, p21 and p-p38 was detected by western blot analysis. The results demonstrated that the overexpression of miR-216b-3p increased the expression of p53 and p21, and decreased the expression of p-p38. These effects also appeared to be eliminated by PBK/TOPK overexpression ([Fig. 6](#f6-etm-0-0-6020){ref-type="fig"}).

Discussion
==========

According a previous report, miRNAs serve a regulatory role in cell growth, proliferation, apoptosis, differentiation, migration and metabolism ([@b34-etm-0-0-6020]). In the present study, the expression of miR-216b-3p was detected in a variety of lung adenocarcinoma cell lines and the results demonstrated that within all lung adenocarcinoma cell lines (A549, GLC-82 and H358 cells), miR-216b-3p expression levels was significantly lower compared with BEAS-2B cells. This indicated that miR-216b-3p was associated with lung adenocarcinoma. GLC-82 cells, which expressed the lowest level of miR-216b-3b, were selected for further analysis.

PBK/TOPK gene expression is increased in various types of cancer, including bladder cancer, brain tumors, breast cancer, liver cancer, lung cancer and sarcoma ([@b35-etm-0-0-6020],[@b36-etm-0-0-6020]). In the present study, the expression levels of PBK/TOPK were observed to be significantly increased within lung adenocarcinoma cells. These results suggested that the expression of miR-216b-3p and PBK/TOPK was dysregulated in lung cancer. Therefore, miR-216b-3p may be involved in tumor development by regulating PBK/TOPK expression. TargetScan was used to predict the target gene of miR-216b-3p, which suggested that miR-216b-3p was targeted to PBK and a double luciferase reporter gene system validated this result. Furthermore, the overexpression of miR-216b-3p in GLC-82 cells significantly inhibited cell proliferation and induced cell apoptosis; when co-transfected with PBK/TOPK, the inhibitory effect exerted by miR-216b-3p was reversed. These results indicated that miR-216b-3p may be considered to be a tumor suppressor by decreasing the expression of PBK/TOPK.

As a member of the mitogen-activated protein kinase kinase family, PBK/TOPK protein is highly expressed in various types of cancer. p53 is considered to be one of the most common tumor suppressors; wild type p53 is involved in apoptosis, cell-cycle arrest and DNA repair ([@b37-etm-0-0-6020]). The loss of p53 function caused by mutations, however, is associated with the majority of human cancers ([@b38-etm-0-0-6020]). Mutant p53 is able to not only promote invasion, migration and proliferation, but also enhance genomic instability and chemoresistance ([@b39-etm-0-0-6020]). It was reported that a p53 mutation is closely associated with the occurrence and progression of lung cancer ([@b40-etm-0-0-6020]). Additionally, Hu *et al* ([@b7-etm-0-0-6020]) revealed that PBK/TOPK may inhibit p53 function and promote the development and progression of tumor cells. The expression levels of p53, p21 and p-p38 were also determined in the present study, and the data demonstrated that the overexpression of miR-216b-3p may inhibit PBK/TOPK. Thus, increases in p53 and p21, and decreases in p-p38 expression, may exert an antitumor effect.

In summary, the present study provided novel evidence that decreased miR-216b-3p expression may contribute to lung adenocarcinoma development by increasing the expression of PBK/TOPK. Furthermore, PBK/TOPK expression may be beneficial to the promotion of cell proliferation and viability. Therefore, miR-216b-3p and PBK/TOPK may be considered as potential clinical indicators and therapeutic targets for the treatment of lung adenocarcinoma.
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![Expression levels of miR-216b-3p in lung adenocarcinoma cell lines. Relative miR-216b-3p expression levels in lung adenocarcinoma cell lines (A549, GLC-82 and H358) and human normal lung epithelial cell line, BEAS-2B, were determined by reverse transcription-quantitative polymerase chain reaction. Data are expressed as the mean ± standard deviation. \*P\<0.05 and \*\*P\<0.01 vs. BEAS-2B. miR, microRNA.](etm-15-06-4822-g00){#f1-etm-0-0-6020}

![PBK/TOPK protein and mRNA expression levels in lung adenocarcinoma cell lines. (A) PBK/TOPK protein expression levels in lung adenocarcinoma cell lines (A549, GLC-82 and H358) and human normal lung epithelial cell line BEAS-2B; (B) PBK/TOPK mRNA expression levels in lung adenocarcinoma cell lines (A549, GLC-82 and H358) and human normal lung epithelial cell line BEAS-2B. Data are expressed as the mean ± standard deviation. \*\*P\<0.01 vs. BEAS-2B. PBK/TOPK, PDZ-binding-kinase/T-LAK cell-originated protein kinase.](etm-15-06-4822-g01){#f2-etm-0-0-6020}

![PBK is a target gene of miR-216b-3p. (A) TargetScan was applied to predict the interaction between miR-216b-3p and 3′UTR of PBK. (B) Luciferase activity was detected via a dual luciferase assay. (C) Relative miR-216b-3p expression levels in GLC-82 cells. (D) Effects of miR-216b-3p on PBK/TOPK protein expression in GLC-82 cells were determined by western blotting. (E) Effects of miR-216b-3p on PBK/TOPK mRNA expression in GLC-82 cells were determined by reverse transcription-quantitative polymerase chain reaction. (F) Relative PBK/TOPK mRNA expression levels in GLC-82 cells. Data are presented as the mean ± standard deviation. \*\*P\<0.01 vs. control. Control, control group, cells without any treatment; NC, negative control group, cells transfected with the negative control vector of miR-216b-3p mimics; mimic, cells transfected with miR-216b-3p mimics; plasmid, cells transfected with PBK/TOPK plasmids; LUC, luciferase; miR, microRNA; PBK/TOPK, PDZ-binding-kinase/T-LAK cell-originated protein kinase; MUT, mutated 3′-untranslated region; WT, wild type 3′-untranslated region.](etm-15-06-4822-g02){#f3-etm-0-0-6020}

![Effects of miR-216b-3p on GLC-82 cell proliferation. At 48 h post-transfection, an MTT assay was used to determine the effect of miR-216b-3p on GLC-82 cell proliferation. Data are presented as the mean ± standard deviation. \*\*P\<0.01 vs. control; ^\#\#^P\<0.01 vs. mimic. Control, control group, cells without any treatment; NC, negative control group, cells transfected with the negative control vector of miR-216b-3p mimics; mimic, cells transfected with miR-216b-3p mimics; mimic + plasmid, cells co-transfected with miR-216b-3p mimics and PDZ-binding-kinase/T-LAK cell-originated protein kinase plasmids; miR, microRNA.](etm-15-06-4822-g03){#f4-etm-0-0-6020}

![Effects of miR-216b-3p on GLC-82 cell apoptosis. (A) At 48 h post-transfection, flow cytometry was performed to determine the effect of miR-216b-3p on GLC-82 cell apoptosis. Cell apoptosis=early apoptosis (lower right quadrant) + late apoptosis (upper right quadrant). (B) Data are presented as the mean ± standard deviation. \*\*P\<0.01 vs. control; ^\#\#^P\<0.01 vs. mimic. Control, control group, cells without any treatment; NC, negative control group, cells transfected with the negative control vector of miR-216b-3p mimics; mimic, cells transfected with miR-216b-3p mimics; mimic + plasmid, cells co-transfected with miR-216b-3p mimics and PDZ-binding-kinase/T-LAK cell-originated protein kinase plasmids; miR, microRNA.](etm-15-06-4822-g04){#f5-etm-0-0-6020}

![Effects of miR-216b-3p on the expression of p53, p21 and p-p38 in GLC-82 cells. After 48 h post-transfection, western blotting was performed to determine the effect of miR-216b-3p the expression of p53, p21 and p-p38 in GLC-82 cells. Control, control group, cells without any treatment; NC, negative control group, cells transfected with the negative control vector of miR-216b-3p mimics; mimic, cells transfected with miR-216b-3p mimics; mimic + plasmid, cells co-transfected with miR-216b-3p mimics and PDZ-binding-kinase/T-LAK cell-originated protein kinase plasmids. miR, microRNA; p-, phosphorylated.](etm-15-06-4822-g05){#f6-etm-0-0-6020}
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